Please try another search
Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan. The company’s products include electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, sirolimus eluting coronary stent system, eucaLIMUS, and eucaVI; clinical nutrition products, such as aminoleban oral, proten gold, pan-amin G, aminoleban injection, and aminovel 600; and therapeutic drugs, which include mucosta tablets and pletaal, as well as oral rehydration therapy. It also engages in the trading of pharmaceutical products, nutritional foods, and medical equipment. Further, the company offers Made in Germany CE-marked drug-eluting coronary stents, PTCA balloon catheters, and other coronary angioplasty accessories and electrophysiology products. The company was incorporated in 1988 and is headquartered in Karachi, Pakistan.
Name | Age | Since | Title |
---|---|---|---|
Rao Sajid Ali Khan | - | 2012 | CFO, Finance Director, Information Technology Head & Company Secretary |
Mikio Bando | - | 2016 | Chairman |
Navin Salim Merchant | - | 2018 | Independent Director |
Moin-ur Rehman | - | 2023 | CEO, GM of Marketing & Medical Devices and Director |
Tariq Mehtabuddin Feroz | - | 2024 | Director |
Muhammad Taufiq Feroz | - | 2021 | Alternate Director |
Koichi Okada | - | 2020 | Non-Executive Director |
Suhari Mukti | - | 2016 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review